Clinical Cancer Research Targets Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 920, February 1, 2007. doi: 10.1158/1078-0432.CCR-06-1695
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riethdorf, S.
Right arrow Articles by Pantel, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riethdorf, S.
Right arrow Articles by Pantel, K.

Imaging, Diagnosis, Prognosis

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Sabine Riethdorf1, Herbert Fritsche4, Volkmar Müller3, Thomas Rau2, Christian Schindlbeck6, Brigitte Rack6, Wolfgang Janni6, Cornelia Coith1, Katrin Beck3, Fritz Jänicke3, Summer Jackson4, Terrie Gornet4, Massimo Cristofanilli5 and Klaus Pantel1

Authors' Affiliations: Institutes of 1 Tumor Biology and 2 Pharmacology and 3 Clinic of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Departments of 4 Laboratory Medicine and 5 Breast Medical Oncology, M. D. Anderson Cancer Center, Houston, Texas; and 6 Department of Obstetrics and Gynecology, Innenstadt, Klinikum of the Ludwig Maximilians University of Munich, Munich, Germany

Requests for reprints: Klaus Pantel, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Phone: 49-40-42803-3503; Fax: 49-40-42803-5379; E-mail: pantel{at}uke.uni-hamburg.de.

Purpose: The CellSearch system (Veridex, Warren, NJ) is designed to enrich and enumerate circulating tumor cells (CTCs) from peripheral blood. Here, we validated the analytic performance of this system for clinical use in patients with metastatic breast cancer.

Experimental Design: This prospective multicenter study conducted at three independent laboratories involved samples from 92 patients with metastatic breast cancer. Intra- and inter-assay variability using controls containing defined numbers of cells (average, 50 and 1,000, respectively), cell stability based on varying storage and shipment conditions, recovery precision from samples spiked with 4 to 12 tumor cells, inter-instrument variability, and positivity of samples from metastatic breast cancer patients were tested.

Results: Intra- and inter-assay precision for two sites were high: All eight positive controls analyzed in the same run and >95% of the run to run control values (n = 299) were within the specified ranges. Recovery rate of spiked samples averaged between 80% and 82%. CTCs were detected in ~70% of metastatic breast cancer patients. CTC values of identical samples processed either immediately after blood drawing or after storage for 24, 48, or 72 h at room temperature or at 4°C did not differ significantly. Shipment of samples had no influence on CTC values. When analyzing identical samples in different centers, inter-instrument accordance was high.

Conclusions: The CellSearch system enables the reliable detection of CTCs in blood and is suitable for the routine assessment of metastatic breast cancer patients in the clinical laboratory. Blood samples should be shipped at room temperature and CTC counts are stable for at least 72 h.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
Y. Okumura, F. Tanaka, K. Yoneda, M. Hashimoto, T. Takuwa, N. Kondo, and S. Hasegawa
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Helo, A. M. Cronin, D. C. Danila, S. Wenske, R. Gonzalez-Espinoza, A. Anand, M. Koscuiszka, R.-M. Vaananen, K. Pettersson, F. K.-H. Chun, et al.
Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival
Clin. Chem., April 1, 2009; 55(4): 765 - 773.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. C. C. Wong, C. M. L. Chan, B. B. Y. Ma, E. P. Hui, S. S. M. Ng, P. B. S. Lai, M. T. Cheung, E. S. F. Lo, A. K. C. Chan, M. Y. Y. Lam, et al.
Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
Clin. Cancer Res., February 1, 2009; 15(3): 1005 - 1012.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. M. Sieuwerts, J. Kraan, J. Bolt, P. van der Spoel, F. Elstrodt, M. Schutte, J. W. M. Martens, J.-W. Gratama, S. Sleijfer, and J. A. Foekens
Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
J Natl Cancer Inst, January 7, 2009; 101(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-Y. Pierga, F.-C. Bidard, C. Mathiot, E. Brain, S. Delaloge, S. Giachetti, P. de Cremoux, R. Salmon, A. Vincent-Salomon, and M. Marty
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Clin. Cancer Res., November 1, 2008; 14(21): 7004 - 7010.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Alix-Panabieres, S. Riethdorf, and K. Pantel
Circulating Tumor Cells and Bone Marrow Micrometastasis
Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Cristofanilli, J. Reuben, and J. Uhr
Circulating Tumor Cells in Breast Cancer: Fiction or Reality?
J. Clin. Oncol., July 20, 2008; 26(21): 3656 - 3657.
[Full Text] [PDF]


Home page
Ann OncolHome page
F. Nole, E. Munzone, L. Zorzino, I. Minchella, M. Salvatici, E. Botteri, M. Medici, E. Verri, L. Adamoli, N. Rotmensz, et al.
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
Ann. Onc., May 1, 2008; 19(5): 891 - 897.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Sastre, M. L. Maestro, J. Puente, S. Veganzones, R. Alfonso, S. Rafael, J. A. Garcia-Saenz, M. Vidaurreta, M. Martin, M. Arroyo, et al.
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Ann. Onc., May 1, 2008; 19(5): 935 - 938.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
K. Pantel, C. Alix-Panabieres, and S. Riethdorf
Circulating Tumor Cells: Detection and Clinical Relevance
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 603 - 610.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
B. H Brandt
Single/Oligo-Cell PCR: Needs, Perspectives, and Limitations
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 625 - 628.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
F.-C. Bidard, A. Vincent-Salomon, B. Sigal-Zafrani, V. Dieras, C. Mathiot, L. Mignot, J.-P. Thiery, X. Sastre-Garau, and J.-Y. Pierga
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
Ann. Onc., March 1, 2008; 19(3): 496 - 500.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. Stojadinovic, E. A. Mittendorf, J. P. Holmes, A. Amin, M. T. Hueman, S. Ponniah, and G. E. Peoples
Quantification and Phenotypic Characterization of Circulating Tumor Cells for Monitoring Response to a Preventive HER2/neu Vaccine-Based Immunotherapy for Breast Cancer: A Pilot Study
Ann. Surg. Oncol., December 1, 2007; 14(12): 3359 - 3368.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Xi, D. G. Nicastri, T. El-Hefnawy, S. J. Hughes, J. D. Luketich, and T. E. Godfrey
Optimal Markers for Real-Time Quantitative Reverse Transcription PCR Detection of Circulating Tumor Cells from Melanoma, Breast, Colon, Esophageal, Head and Neck, and Lung Cancers
Clin. Chem., July 1, 2007; 53(7): 1206 - 1215.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.